How a Single Gene Loss Helps Melanoma Outsmart Targeted Drugs
An integrative multi-omics study reveals how loss of the chromatin factor ARID1A rewires receptor and kinase signaling in melanoma, driving ...
An integrative multi-omics study reveals how loss of the chromatin factor ARID1A rewires receptor and kinase signaling in melanoma, driving ...
A new narrative review concludes that the truncated ALK ATI transcript is a context-dependent biological phenomenon rather than a validated ...
A phase II pilot trial found that the IDO1 inhibitor epacadostat safely reduced kynurenine-to-tryptophan ratios in advanced melanoma patients but ...
Researchers have identified a bone marrow-derived CD11c-positive B220-positive NK cell subset selectively expanded by IL-15 that outperforms conventional NK cells ...
A UC Davis clinical trial found that doxorubicin lymphodepletion before inhaled interleukin-15 therapy did not improve response rates in dogs ...
A 45-year nationwide analysis of more than 60,000 Norwegian melanoma cases shows incidence rising steeply in older adults, especially men, ...
A new commentary argues that the RNA modification-based RMODscore for melanoma prognosis should undergo privacy-preserving federated validation across multiple hospitals ...
A new analysis of the 2024 National Health Interview Survey reveals how the contexts in which U.S. adults experience sunburn ...
A new review details how tumor-infiltrating lymphocyte, CAR-T, and TCR-engineered cell therapies are transforming melanoma treatment and the engineering breakthroughs ...
Researchers in Iraq and Oman have engineered a modified ConvNeXt V2 deep learning model that classifies dermoscopic skin lesions with ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine